
Welcure Drugs (WELCURE) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
245.5M
Gross Profit
40.5M
16.48%
Operating Income
8.7M
3.54%
Net Income
21.7M
8.84%
Balance Sheet Metrics
Total Assets
2.7B
Total Liabilities
1.6B
Shareholders Equity
1.0B
Debt to Equity
1.60
Cash Flow Metrics
Operating Cash Flow
-2.2B
Free Cash Flow
-2.2B
Revenue & Profitability Trend
Welcure Drugs Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 245.5M | 0 | 0 | 1.0M | 1.3M |
Cost of Goods Sold | 205.0M | 0 | 0 | 0 | 0 |
Gross Profit | 40.5M | 0 | 0 | 0 | 0 |
Operating Expenses | 28.9M | 1.1M | 899.0K | 661.1K | 679.8K |
Operating Income | 8.7M | -2.7M | -1.4M | 236.5K | 550.2K |
Pre-tax Income | 27.8M | -1.7M | 1.0M | 235.8K | 551.5K |
Income Tax | 6.1M | 0 | 0 | 0 | 0 |
Net Income | 21.7M | -1.7M | 1.0M | 235.8K | 551.5K |
EPS (Diluted) | - | -₹0.13 | ₹0.08 | ₹0.02 | ₹0.05 |
Income Statement Trend
Welcure Drugs Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 1.8B | 318.0K | 59.0K | 660.1K | 474.6K |
Non-Current Assets | 848.4M | 13.4M | 15.2M | 308.1K | 255.6K |
Total Assets | 2.7B | 13.7M | 15.3M | 968.2K | 730.2K |
Liabilities | |||||
Current Liabilities | 412.7M | 306.0K | 136.0K | 38.2K | 35.9K |
Non-Current Liabilities | 1.2B | 0 | 0 | 0 | 0 |
Total Liabilities | 1.6B | 306.0K | 136.0K | 38.2K | 35.9K |
Equity | |||||
Total Shareholders Equity | 1.0B | 13.4M | 15.2M | 930.0K | 694.2K |
Balance Sheet Composition
Welcure Drugs Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 27.8M | -1.7M | 1.0M | 235.8K | 551.5K |
Operating Cash Flow | -2.2B | -1.6M | 1.1M | 185.5K | 421.9K |
Investing Activities | |||||
Capital Expenditures | -170.0K | - | - | - | - |
Investing Cash Flow | -635.0K | 1.6M | 0 | - | - |
Financing Activities | |||||
Dividends Paid | - | - | - | - | - |
Financing Cash Flow | 2.2B | -171.0K | -1.7M | - | - |
Free Cash Flow | -2.2B | -1.3M | 1.1M | 185.5K | 421.9K |
Cash Flow Trend
Welcure Drugs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
39.86
Price to Book
1.08
Price to Sales
6.58
Profitability Ratios
Profit Margin
8.84%
Operating Margin
2.97%
Return on Equity
4.18%
Return on Assets
1.29%
Financial Health
Current Ratio
4.41
Debt to Equity
120.18
Beta
-1.28
Per Share Data
EPS (TTM)
₹0.36
Book Value per Share
₹13.32
Revenue per Share
₹4.07
Financial data is updated regularly. All figures are in the company's reporting currency.